Putting Fama–French Factors to Work — Smart-Beta ETFs

You've probably heard something like "value stocks beat the market over the long run." That isn't a hunch — it's a premium that the Fama–French factor model demonstrated with data. The good news: those factors have left the textbook and become products you can buy as a single ETF (smart beta). Here's what the factors are, which ETFs capture them, and what to check before you buy.

Eugene Fama and Kenneth French combed through decades of data and found that, beyond the market's overall ups and downs (the market factor), certain kinds of stocks earned extra return over the long run: small companies (size, SMB), cheap companies (value, HML), and — added in the 5-factor model — highly profitable firms (RMW) and conservatively-investing firms (CMA). That leftover return is called a factor premium.

One thing to be clear about: this premium is not free. Each factor carries its own risk (value stocks bear recession and distress risk; small caps bear liquidity and survival risk), and the premium is the reward paid to investors who bear that risk. In other words, "tilting" toward a factor is the same as taking on more of its risk — beta, risk and expected return are one and the same.

Asset managers took it one step further: "If we build an ETF that systematically tilts toward that factor, individuals could chase the premium too." That's how smart-beta (factor) ETFs were born — a rule-based "third way" between pure passive (cap-weighted, e.g. the S&P 500) and discretionary active management. They encode an academic factor as a rule and automatically lean toward stocks with that character.

Below are the main factors and the US- and Korea-listed smart-beta ETFs that target them (just the essentials). Momentum and low-volatility aren't in the Fama–French 3/5-factor models, but they belong to the same "rule-based factor" family.

The key idea: smart beta = a deliberate tilt away from cap-weighting. Buy VLUE and you lean toward value vs the market; buy QUAL and you lean toward quality. You get a more distinct "flavor" than plain passive, but the expense ratio is a bit higher than a cap-weighted ETF and it won't track the market one-for-one.

Does it really? — Run it through DIVA

You don't have to take the table on faith. We dropped two of them into DIVA Quantizer's return-factor analysis (FF5) on their own (US-listed, ~6 years of monthly data). The result is clear: each ETF loads significantly on the factor it targets — and little else.

VLUE loads on value (HML) and QUAL on quality (RMW), each with a significant beta of +0.3–0.4 — exactly the factor on the tin. And both have alpha (return beyond the factors) statistically near zero. So these ETFs' returns come not from hidden magic but from the factor exposure itself — which is the price of bearing that factor's risk.

The single most important premise: raising your beta to a factor means taking on that factor's risk in equal measure, and the expected return (premium) is the compensation for bearing it. Tilt toward value and you take on "the risk that value stays out of favor for years" along with the upside; tilt toward small caps and you take on liquidity and survival risk. Beta, risk and expected return don't move independently — raise one and all three move together.

So blindly maxing every factor beta is not the answer — it can stack risk rather than expected return. Instead, set the betas you'll target based on your risk tolerance, horizon and market view: if you can stomach volatility and long droughts, aim for value (β_HML↑) and size (β_SMB↑); to play defense, lean to quality (β_RMW↑) and low volatility; if you're betting on a value comeback, set a positive β_HML target.

In practice it's cleaner to narrow to one or two factors. Aiming at too many at once can cancel out (value vs momentum) or just drift back toward the market while costing more. In the end, "which risks am I willing to bear for their reward?" is the question that sets your target betas.

With your target betas chosen, now check which factors your current portfolio already leans toward and read off "target − current = the gap." If you hold a pile of US big tech, you may already be heavily exposed to growth (the opposite of value) and high volatility — adding a momentum ETF on top doubles down on the very same risk.

This is exactly where DIVA Quantizer's return-factor analysis comes in. Feed in your portfolio and it shows your exposure (β) to each factor — market (MKT), size (SMB), value (HML), profitability (RMW), investment (CMA) — as a center-anchored bar. A bar to the right of center (0; for market β, 1) means a positive tilt to that factor; to the left, a negative tilt.

That makes the decision simple: don't add more of a factor you already exceed your target on (redundant, excess risk), and use smart beta only to fill the factors that fall short. Say your target is value-neutral but DIVA shows your β_HML deeply negative (a growth tilt) — you might add a small value ETF (like VLUE) to close the gap, never forgetting that raising the beta raises that risk too. A tilt grounded in numbers, not a vague hunch.

Factor investing is no longer a paper-only idea — it's a tool anyone can buy as an ETF. But before "what should I buy," the right order is to know "what am I already holding." Start by laying out your portfolio's factor map.

This article was written with the help of AI.